Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

SynHealth

Financiado

Synergy for Healthy Longevity

Almost all current healthcare systems are based on treating individuals who are already ill, relying on periodic interventions when health is compromised, and health problems hinder normal functioning. This approach is becoming in... ver más

28/02/2027

GENOS

1M€

Presupuesto del proyecto: 1M€

Líder del proyecto

GENOS DOO ZA VJESTACENJE I ANALIZU No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 7 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-03-01

HORIZON-WIDERA-2023-ACCESS-04-01: Pathways to Synergies Expected Outcome:Synergies between Horizon Europe and the cohesion policy programmes, mainly the Eur...

Innovación

Cerrada hace 1 año

0% 100% 100%

7 Participantes

GENOS

488.88K€ | Lider

HAMAG-BICRO

N.D. | Participante

ULIEGE

98.75K€ | Participante

GlycanAge

200.00K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

Proceed Pharmacoepigenetics for precision medicine in type 2 diabete... 150K€ Cerrado

PredicGenX Responsible prediction of gene expression: mitigating geneti... 176K€ Cerrado

BFU2012-33594 CONTROL EPIGENETICO DE LA ADAPTACION DE LA CELULA BETA A LA... 47K€ Cerrado

PredRegNetworks Listening to Silence: The First Blood Test for Risk of Indiv... 150K€ Cerrado

PID2021-123781OB-C21 DESCIFRANDO EL CODIGO DEL RECONOCIMIENTO MOLECULAR DE GLICAN... 387K€ Cerrado

MTM2014-52975-C2-1-R INFERENCIA EN LOS MODELOS DE REGRESION ADITIVOS ESTRUCTURADO... 58K€ Cerrado

Duración del proyecto: 35 meses Fecha Inicio: 2024-03-01
Fecha Fin: 2027-02-28

Líder del proyecto

GENOS DOO ZA VJESTACENJE I ANALIZU No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 1M€

Descripción del proyecto Almost all current healthcare systems are based on treating individuals who are already ill, relying on periodic interventions when health is compromised, and health problems hinder normal functioning. This approach is becoming increasingly financially unsustainable, and healthcare funding is in a continuous crisis at a global level. In the field of health promotion, glycans (complex oligosaccharides) have the highest biomarker potential since they integrate genetic, epigenetic and lifestyle factors, making them more similar to complex diseases than any other class of molecules. Researchers in Genos pioneered high-throughput glycomics 15 years ago, which enabled glycomics to become integrated in multiple large epidemiological and clinical studies. Through active participation in multiple EU-funded projects, including 3TR and SYSCID that are formal requirement for this application, researchers in Genos analysed over 200,000 individual glycomes and identified several potential glycan biomarkers. General objective of the SynHealth project is to valorise the potential of these research discoveries (glycan biomarkers) and prepare them for ERDF funding and subsequent exploitation in two Croatian and one Slovenian regions together with the University of Maribor. This will be achieved with the support of past Horizon partners Karolinska Institute and University of Liege. Innovation capacity and technology uptake will be further supported by the dedicated innovation management and technology transfer partner F6S, and GlycanAge SME partner that actively commercialises glycan biomarkers in the general health and wellness sector. Adoption of glycan biomarkers for personalised preventive healthcare will be demonstrated in real world setting and supported through a network of partners in the region. This will all prepare discoveries from past Horizon projects (glycan biomarkers) for future translation into clinical diagnostic biomarkers through support of ERDF funding.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores